United States guidance directory
Search source-attributed educational summaries available for this region.
190 pages
Adult hypertension screening and confirmation
A source-separated US summary of adult blood-pressure screening, out-of-office confirmation and classification.
Prediabetes and type 2 diabetes screening and diagnosis
US screening eligibility and diagnostic thresholds for asymptomatic, nonpregnant adults, with USPSTF and ADA recommendations kept separate.
Osteoporosis screening to prevent fractures
A bounded summary of the 2025 USPSTF primary-screening recommendations and evidence limits.
Atrial fibrillation
Current US assessment, stroke-prevention, risk-factor, rate-control and rhythm-control priorities for adults with atrial fibrillation.
Chronic heart failure
US staging, phenotype confirmation, guideline-directed therapy, monitoring and referral priorities for adults with chronic heart failure.
Venous thromboembolism (DVT and pulmonary embolism)
Current US diagnosis, severity assessment, anticoagulation, disposition and follow-up priorities for DVT and acute pulmonary embolism.
Dyslipidemia and statin-based prevention
The 2026 ACC/AHA US pathway for lipid assessment, PREVENT risk estimation, statin treatment, goals and selective nonstatin intensification.
Stroke and transient ischemic attack
US emergency recognition and current acute ischemic-stroke and secondary-prevention priorities for stroke and TIA.
Chest pain of recent onset
US recognition, structured risk assessment and evidence-based testing priorities for acute and stable chest pain.
Adult valvular heart disease
US evaluation, staging, surveillance and multidisciplinary intervention planning for adult valvular heart disease.
Lower-extremity peripheral artery disease
Current US detection, cardiovascular and limb-risk treatment, exercise, foot care and revascularization priorities for lower-extremity PAD.
Familial hypercholesterolemia
US recognition, family assessment, early LDL lowering and specialist escalation for suspected or confirmed familial hypercholesterolemia.
Transient loss of consciousness and syncope
US initial assessment, risk stratification and targeted testing for syncope and other transient loss of consciousness.
Inclisiran for hypercholesterolemia
US FDA-label and 2026 dyslipidemia-guideline context for selecting, administering and monitoring inclisiran.
Abdominal aortic aneurysm
US preventive screening, incidental finding, surveillance and urgent escalation for abdominal aortic aneurysm.
Stable angina and chronic coronary disease
US symptom control, event prevention, exercise, testing and revascularization priorities for chronic coronary disease with angina.
Palpitations and suspected supraventricular tachycardia
US rhythm documentation, stability assessment, targeted monitoring and management principles for palpitations and adult SVT.
Acute heart failure
US recognition, stabilization, congestion treatment, precipitant assessment and transition priorities for acute heart failure.
Acute coronary syndromes
Current 2025 US triage, antithrombotic, invasive, revascularization and post-discharge priorities for unstable angina, NSTEMI and STEMI.
Asthma diagnosis and longitudinal care
US-focused asthma confirmation, anti-inflammatory treatment, control review, action planning and exacerbation safety for children and adults.
Chronic obstructive pulmonary disease
Current COPD confirmation, symptom and exacerbation assessment, inhaled treatment, prevention and acute deterioration priorities for US practice.
Community-acquired pneumonia in adults
ATS/IDSA-based adult CAP confirmation, site-of-care decisions, microbiology, empiric treatment, stability review and safety escalation.
Obstructive sleep apnea and obesity hypoventilation
AASM and ATS pathways for adult sleep-apnea testing, PAP treatment, obesity-hypoventilation evaluation and urgent respiratory safety.
Allergic and nonallergic rhinitis
US allergy-practice guidance for rhinitis classification, targeted testing, intranasal therapy, comorbidity and escalation.
Chronic cough in adults
CHEST-based classification, red-flag screening, common-cause evaluation, sequential management and referral for cough lasting more than eight weeks.
Adult non-cystic-fibrosis bronchiectasis
The 2026 CHEST approach to exacerbation antibiotics, airway clearance, suppressive treatment, hemoptysis and selected surgery.
Chronic kidney disease evaluation and management
KDIGO 2024 confirmation, GFR and albuminuria classification, progression risk, kidney-protective treatment and referral for US care.
Acute kidney injury recognition and initial management
KDIGO-based AKI detection, staging, cause evaluation, hemodynamic and medicine review, complication management and escalation.
Finerenone for CKD associated with type 2 diabetes
US FDA-label and guideline positioning, eligibility checks, potassium monitoring, interactions and cardiorenal follow-up for finerenone.
Acute kidney and ureteral stones: source-status boundary
What the attached AUA directory does and does not establish about the 2026 surgical kidney-stone guideline.
Kidney-stone metabolic evaluation and recurrence prevention
US stone analysis, risk assessment, urine evaluation, diet, phenotype-directed prevention and longitudinal monitoring after nephrolithiasis.
Established primary hypothyroidism: hormone replacement
A source-bounded ATA hormone-replacement summary for established primary hypothyroidism; diagnostic testing for suspected disease is outside scope.
Type 1 diabetes in adults
ADA 2026 insulin, glucose technology, education, hypoglycemia, ketosis prevention and complication care for adults with type 1 diabetes.
Diabetes-related foot prevention and urgent problems
ADA 2026 foot-risk examination, patient education, ulcer, infection, ischemia and Charcot escalation for US care.
Primary adrenal insufficiency and adrenal crisis
Endocrine Society diagnosis, replacement, sick-day preparation and emergency treatment for primary adrenal insufficiency.
Adult hyponatremia: diagnosis and safe correction
A cautious US-oriented approach to tonicity, symptom and duration assessment, etiologic testing, monitored treatment and overcorrection prevention.
Primary hyperparathyroidism
Fifth International Workshop confirmation, target-organ evaluation, surgery selection, monitoring and hypercalcemia safety.
Vitamin D testing, prevention and established indications
A scope-safe reading of the 2024 Endocrine Society guideline, separating population prevention from diagnosis and treatment of established vitamin D disorders.
Acne vulgaris assessment and management
AAD-based acne severity assessment, combination topical treatment, antibiotic stewardship, isotretinoin referral and scar prevention for US practice.
Atopic dermatitis across the lifespan
Current AAD topical, systemic and pediatric principles for diagnosing atopic dermatitis, restoring the skin barrier, controlling inflammation and escalating safely.
Psoriasis assessment and treatment selection
AAD–NPF assessment of cutaneous psoriasis, high-impact sites, psoriatic arthritis, comorbidity, topical care and specialist escalation in US practice.
Scabies recognition, treatment and contact control
CDC-based classic and crusted scabies treatment, simultaneous contact management, environmental measures and post-treatment review.
Tinea corporis, cruris and pedis
CDC-based diagnosis, topical treatment, steroid avoidance, resistant dermatophyte recognition and escalation for common cutaneous tinea.
Phenotype-led rosacea care
National Rosacea Society consensus for diagnosing rosacea by phenotype, selecting feature-specific treatment and recognizing ocular disease.
Alopecia areata recognition and treatment planning
US diagnosis, severity documentation, limited-disease options, referral and current FDA-labeled systemic treatment context for alopecia areata.
Baricitinib for severe alopecia areata
FDA-labeled adult severe-alopecia use of baricitinib, with pretreatment evaluation, risk selection, monitoring and the June 2026 hypoglycemia warning.
Ritlecitinib for severe alopecia areata
June 2026 FDA-labeled use of ritlecitinib for adults and adolescents aged 12 years or older, including baseline testing and JAK-class safety.
Adult overweight and obesity management
US intensive behavioral treatment and obesity pharmacotherapy, with metabolic-surgery eligibility retained as an explicit evidence gap.
Semaglutide (Wegovy) for chronic weight management
Current US Wegovy indications, formulation-specific initiation, monitoring, contraindications and long-term treatment review.
Tirzepatide (Zepbound) for chronic weight management
Current US Zepbound eligibility, dose escalation, monitoring, interactions, reproductive counseling and serious adverse-effect boundaries.
Dapagliflozin (Farxiga) for chronic kidney disease
FDA-label and KDIGO positioning, renal-function and volume checks, ketoacidosis prevention, infection safety and peri-procedural planning.
Empagliflozin (Jardiance) for chronic kidney disease
FDA-label and KDIGO positioning, kidney and volume assessment, ketoacidosis and infection safety, and coordinated CKD follow-up.
Nosebleed assessment and control
AAO-HNSF first aid, focused examination, packing and cautery principles, antithrombotic safety and referral for epistaxis in patients aged three years or older.
Acute red eye triage in ambulatory care
AAO-based differentiation of uncomplicated conjunctivitis from keratitis and other sight-threatening red-eye presentations, with contact-lens and referral safety.
Measles recognition, isolation and public-health response
CDC 2026 recognition, immediate airborne precautions, paired PCR and serology, mandatory reporting, supportive care and exposure coordination.
Child and adolescent immunization review
A safe workflow for applying the current CDC/ACIP age, catch-up, medical-indication and special-situation schedules without freezing a changing vaccine table.
Adult immunization review
CDC/ACIP age-based, risk-based, pregnancy, catch-up and shared-decision vaccination workflow for US adults.
Syphilis diagnosis, staging and treatment
CDC stage-specific serology, penicillin treatment, pregnancy, neurologic and ocular escalation, partner services and response monitoring.
Gonorrhea testing, treatment and resistance response
CDC anatomic-site testing, weight-based ceftriaxone treatment, chlamydia coverage, pharyngeal test of cure, partner care and suspected resistance escalation.
HIV preexposure prophylaxis
CDC HIV PrEP eligibility, baseline exclusion of acute HIV, oral and injectable choices, kidney and hepatitis B safety and continuing monitoring.
HIV nonoccupational postexposure prophylaxis
CDC 2025 emergency nPEP evaluation, prompt three-drug initiation, 28-day completion, exposure-source testing and transition to PrEP.
Urinary tract infection assessment and stewardship
US-focused differentiation of bladder-limited and systemic urinary infection, selective testing, empiric treatment review and safety escalation.
Lower urinary tract infection in women
A US pathway for acute cystitis in nonpregnant and pregnant patients, with explicit boundaries for pyelonephritis and asymptomatic bacteriuria.
Acute sore throat and streptococcal pharyngitis
US risk assessment, selective group A streptococcal testing, antibiotic stewardship and deep-neck-infection safety for children and adults.
Acute otitis media in children
US pediatric diagnostic criteria, pain treatment, observation options, antimicrobial stewardship and complication escalation.
Adult rhinosinusitis
US differentiation of viral and bacterial acute rhinosinusitis, shared treatment decisions, chronic-disease confirmation and safety referral.
Lyme disease prevention, diagnosis and treatment
North American tick-bite risk assessment, erythema migrans diagnosis, staged testing, treatment boundaries and organ-specific escalation.
Acute cough and uncomplicated bronchitis stewardship
US assessment of acute cough, exclusion of pneumonia, antibiotic avoidance and return precautions for uncomplicated bronchitis.
Impetigo and ecthyma
US diagnosis, limited-versus-extensive treatment, culture strategy, transmission control and deeper-infection escalation.
Cellulitis and erysipelas
US distinction of nonpurulent cellulitis from abscess, severity assessment, focused microbiology and necrotizing-infection escalation.
Acute diffuse otitis externa
US diagnosis, pain control, topical first-line therapy, drop-delivery optimization and malignant-otitis-externa escalation.
Long COVID clinical assessment and support
CDC-aligned patient-centered evaluation, symptom-directed care, post-exertional-malaise safety and functional support for Long COVID.
Herpes zoster recognition and early treatment
US diagnosis, timely antiviral treatment, ophthalmic and disseminated-disease escalation, transmission precautions and prevention follow-up.
Infectious conjunctivitis in adults and children
AAO-aligned differentiation of viral, bacterial and high-risk conjunctivitis, antibiotic stewardship and urgent corneal referral.
Nirmatrelvir–ritonavir for outpatient COVID-19
US FDA-label and CDC workflow for time-critical Paxlovid eligibility, interaction reconciliation, organ-function dosing and safety follow-up.
Genital herpes diagnosis, treatment and counseling
CDC-aligned lesion testing, first-episode and recurrent treatment decisions, transmission counseling and pregnancy safety.
Hepatitis B screening and test interpretation
CDC universal adult triple-panel screening, pregnancy and risk-based testing, result interpretation and linkage to liver care.
Hepatitis C screening, confirmation and linkage
CDC universal adult and pregnancy screening, antibody-to-RNA confirmation, reinfection testing and linkage to curative treatment.
HIV screening and diagnostic testing in primary care
USPSTF universal screening, pregnancy testing, repeat risk-based testing, acute-HIV recognition and rapid linkage to care.
Pertussis recognition, treatment and public-health response
CDC-aligned clinical recognition, nasopharyngeal testing, early treatment, post-exposure prophylaxis and infant-risk escalation.
Pinworm infection diagnosis and household control
CDC-based tape testing, two-dose treatment logic, household hygiene and special-population precautions for Enterobius vermicularis.
Dyspepsia and gastroesophageal reflux disease
US evaluation and treatment of uninvestigated dyspepsia and GERD, including endoscopy triggers, H. pylori testing, proton-pump-inhibitor use and objective testing.
Metabolic dysfunction-associated steatotic liver disease
Current US MASLD recognition, noninvasive fibrosis risk stratification, metabolic treatment, referral and cirrhosis surveillance.
Irritable bowel syndrome in adults
ACG-based positive diagnosis, focused exclusion testing, diet, subtype-directed treatment and gut–brain behavioral care for IBS.
Celiac disease
ACG-based case finding, serology and biopsy diagnosis, gluten-free treatment, nutritional assessment and follow-up for celiac disease.
Pharmacologic treatment of chronic idiopathic constipation
The 2023 AGA/ACG medicine recommendations for adults already diagnosed with chronic idiopathic constipation.
Hemorrhoidal disease
ASCRS-based evaluation, bowel-habit treatment, office procedures, surgery selection and rectal-bleeding safety for symptomatic hemorrhoids.
Anal fissure in adults
ASCRS-based recognition and staged care of acute and chronic anal fissure, including conservative care, topical therapy, botulinum toxin and surgery.
Colonic diverticulitis
The 2026 ACG approach to diagnosis, selective outpatient care and antibiotics, recurrence prevention, colon evaluation and individualized surgery.
Suspected inflammatory bowel disease in adults
Current US recognition and diagnostic confirmation of ulcerative colitis and Crohn disease, including infection exclusion, endoscopy, imaging and urgent escalation.
Evaluation of abnormal liver chemistries
ACG-based confirmation, injury-pattern classification, etiologic evaluation and urgency assessment for abnormal aminotransferases, alkaline phosphatase or bilirubin.
Right-upper-quadrant pain and suspected bile-duct stones
A bounded US summary of ACR biliary imaging and ASGE choledocholithiasis risk stratification; operative and antimicrobial management remain outside this source set.
Acute pancreatitis
The 2024 ACG pathway for diagnosis, early severity assessment, fluids, feeding, biliary intervention and pancreatic-necrosis management.
Acute infectious diarrhea in adults
IDSA-based assessment, rehydration, selective stool testing and antibiotic stewardship for acute diarrhea in US and travel settings.
Acute upper gastrointestinal bleeding
ACG-based emergency risk assessment, resuscitation, transfusion, endoscopy, hemostasis and post-endoscopic care for overt upper GI bleeding.
Hand, hip and knee osteoarthritis
ACR/Arthritis Foundation–based nonoperative management for hand, hip and knee osteoarthritis; arthroplasty timing remains an evidence gap.
Low back pain with or without radicular symptoms
VA/DoD-based triage, selective imaging, active rehabilitation, medication stewardship and escalation for acute and chronic low back pain.
Established rheumatoid arthritis: pharmacologic treatment
ACR-based treatment of established rheumatoid arthritis; recognition, diagnostic testing and referral remain an explicit source gap.
Polymyalgia rheumatica
Recognition, exclusion of mimics, glucocorticoid treatment, relapse monitoring and giant-cell-arteritis safety in polymyalgia rheumatica.
Giant cell arteritis
ACR/Vasculitis Foundation–based emergency recognition, diagnostic confirmation, vascular imaging and glucocorticoid-sparing care for GCA.
Established axial spondyloarthritis: treatment
The 2026 ACR treatment update for established axial spondyloarthritis; diagnosis and sacroiliac imaging remain an explicit source gap.
Adult rotator cuff injury
AAOS 2025 evaluation, rehabilitation, injection, imaging and operative decision-making for adult rotator cuff tears.
Carpal tunnel syndrome
AAOS 2024 diagnosis, selective electrodiagnostic testing, splint and injection options, surgical release and postoperative care.
Gout flares and urate-lowering therapy
ACR-based diagnosis, acute flare treatment, allopurinol-first treat-to-target therapy, prophylaxis and comorbidity-aware care.
Headache assessment and primary-headache classification
US-focused secondary-headache triage, phenotype diagnosis, selective testing, medication-overuse prevention and follow-up.
Migraine acute treatment and prevention
US individualized acute and preventive migraine care, medication-overuse control, reproductive safety and escalation.
Adult first unprovoked seizure: prognosis and treatment decision
AAN/AES evidence on recurrence prognosis and whether to start immediate treatment after an adult first unprovoked seizure.
Benign paroxysmal positional vertigo
US bedside diagnosis, canalith repositioning, low-value-test avoidance, fall-risk assessment and central-vertigo escalation.
Bell's palsy recognition and early care
US exclusion of stroke and structural causes, time-sensitive corticosteroid treatment, corneal protection and follow-up.
Adult age-related hearing loss identification and care
US screening, otoscopy, audiologic confirmation, communication support, amplification and urgent asymmetric-loss referral.
Tinnitus assessment and quality-of-life management
US red-flag assessment, audiology, education, sound strategies, cognitive behavioral care and low-value-treatment avoidance.
Trigeminal neuralgia recognition and specialist treatment
US phenotype recognition, structural-cause evaluation, medication safety and neurosurgical referral for trigeminal neuralgia.
Cognitive decline and dementia diagnostic evaluation
US patient-centered recognition, tiered evaluation, collateral history, diagnosis disclosure and early care planning for suspected dementia.
Parkinson disease diagnosis and early motor treatment
US recognition, movement-specialist confirmation, initial dopaminergic treatment and adverse-effect monitoring for early Parkinson disease.
Multiple sclerosis diagnosis and disease-modifying care
US application of the 2024 McDonald criteria, specialist confirmation, individualized disease-modifying therapy and longitudinal safety monitoring.
Distal symmetric polyneuropathy evaluation
A source-bounded AAN summary of laboratory and genetic testing in distal symmetric polyneuropathy; broader management remains blocked.
Amyotrophic lateral sclerosis recognition and multidisciplinary care
US urgent recognition, specialist diagnosis, respiratory and nutrition surveillance, multidisciplinary care and preference-sensitive planning for ALS.
Pediatric ADHD diagnosis and longitudinal treatment
AAP-aligned multi-setting evaluation, comorbidity assessment, age-specific behavioral and medication treatment, school support and monitoring.
Adult autism: federal source-scope boundary
What the attached CDC diagnostic page and HHS lifespan-services research plan do and do not establish for adult autism care.
Lower urinary tract symptoms attributed to benign prostatic hyperplasia
AUA-based evaluation and shared medical or procedural management of bothersome LUTS attributed to benign prostatic hyperplasia.
Male lower urinary tract symptoms: differential and initial pathway
A symptom-led US approach separating bladder storage, outlet obstruction, infection, neurologic dysfunction and retention before treatment.
Erectile dysfunction
AUA-based evaluation of erectile dysfunction as a sexual-health and cardiovascular-risk marker, with staged shared treatment.
Acute epididymitis and epididymo-orchitis
CDC-based torsion exclusion, STI and urinary testing, organism-directed empiric therapy, partner care and follow-up.
Acute nontraumatic scrotal pain: imaging evidence boundary
ACR imaging appropriateness for acute scrotal pain, with operative torsion management kept outside the attached source scope.
Menopause symptom assessment and treatment
The Menopause Society approach to individualized hormone and evidence-based nonhormone treatment for bothersome menopausal symptoms.
Heavy menstrual bleeding and abnormal uterine bleeding
ACOG-based diagnosis and acute abnormal-uterine-bleeding management; chronic stable treatment remains an explicit source gap.
Suspected endometriosis: diagnosis and initial pathway
ACOG 2026 diagnostic guidance for clinical recognition, imaging, presumptive diagnosis and timely shared decisions without mandatory diagnostic surgery.
Hypertensive disorders of pregnancy
ACOG differentiation of chronic and gestational hypertension, preeclampsia surveillance, severe-feature escalation and CHAP-informed treatment.
Diabetes before, during and after pregnancy
ADA 2026 preconception optimization, pregnancy glucose monitoring, insulin-first pharmacotherapy, technology and postpartum follow-up.
Urinary incontinence and pelvic organ prolapse
ACOG/AUGS symptom-led evaluation, conservative care and referral boundaries for urinary leakage and pelvic organ prolapse.
Bacterial vaginosis
CDC diagnosis and treatment of symptomatic bacterial vaginosis with the 2025 ACOG recurrent-BV partner-therapy update.
Vulvovaginal candidiasis
CDC differentiation of uncomplicated, recurrent, severe and non-albicans vulvovaginal candidiasis with pregnancy and resistance boundaries.
Pelvic inflammatory disease
CDC low-threshold diagnosis, empiric broad treatment, hospitalization criteria, partner care and 72-hour response review for acute PID.
Uncomplicated chlamydial infection
CDC testing, site-specific treatment, pregnancy follow-up, partner management and repeat testing for uncomplicated chlamydial infection.
Emergency contraception
CDC U.S. SPR timing, method selection, post-ulipristal contraception and follow-up after emergency contraception.
Ectopic pregnancy and early pregnancy loss
ACOG evaluation of pregnancy of unknown location, ectopic-pregnancy urgency and patient-centered management of confirmed early pregnancy loss.
Combined hormonal contraception
CDC eligibility screening, person-centered initiation, backup and safety follow-up for pills, patches and vaginal rings.
Progestin-only pills
CDC method-specific eligibility, initiation, missed-pill instructions and follow-up for US progestin-only oral contraception.
Long-acting reversible contraception
CDC person-centered initiation and follow-up for intrauterine devices, contraceptive implants and injectable contraception.
Polycystic ovary syndrome
2023 international PCOS diagnostic criteria, life-course risk assessment and goal-directed reproductive, metabolic and symptom management.
Prepregnancy counseling
ACOG and ASRM preparation for pregnancy through reproductive goals, condition and medication optimization, prevention and equitable risk review.
Recurrent pregnancy loss
ASRM 2026 definition, evidence-based staged evaluation, cause-directed treatment and prognosis after recurrent pregnancy loss.
Possible cancer in primary care: symptom-led evaluation
A US symptom-led safety framework for investigating possible cancer without imposing one universal referral clock across organ systems.
Elevated PSA and suspected prostate cancer
AUA/SUO 2026 shared decision, repeat-PSA and risk-adapted urology pathway for possible clinically significant prostate cancer.
Gross and microscopic hematuria
AUA/SUFU 2025 confirmation, risk stratification, cystoscopy and upper-tract evaluation for adult hematuria.
Palpable breast mass: initial imaging and referral
Age- and context-matched ACR imaging, clinical–radiologic concordance and tissue diagnosis for a new palpable breast finding.
Rectal bleeding and iron-deficiency anemia evaluation
A source-bounded US summary of iron-deficiency-anemia evaluation and rectal bleeding when hemorrhoids are suspected; broader cancer symptoms remain blocked.
Suspicious skin lesions: recognition, biopsy and referral
Symptom-led recognition and tissue diagnosis of melanoma and keratinocyte cancer, distinct from population screening.
Possible ovarian cancer and adnexal mass
US ovarian-screening limits and ACR adnexal-mass imaging; oncology referral and procedural planning remain explicit evidence gaps.
Metastatic epidural spinal cord or cauda-equina compression
Emergency recognition, MRI, corticosteroid and multidisciplinary surgical–radiation management of malignant neural compression.
Major depressive disorder assessment and treatment
VA/DoD-aligned adult depression assessment, shared treatment selection, measurement-based follow-up and urgent risk escalation.
Adult anxiety-disorder screening
USPSTF preventive-screening guidance for anxiety disorders in asymptomatic adults, including age limits and the required diagnostic follow-through.
ME/CFS recognition and symptom-prioritized care
CDC-bounded recognition of post-exertional malaise, exclusion of alternatives, energy management and support for severe disease.
Chronic insomnia disorder assessment and treatment
VA/DoD-aligned clinical diagnosis, CBT-I first-line care, selective sleep testing and medication safety review.
Daridorexant for adult insomnia
US FDA-label boundaries for daridorexant placed within CBT-I-first chronic-insomnia assessment and follow-up.
Alcohol misuse and alcohol use disorder
VA/DoD-aligned screening, diagnostic assessment, withdrawal triage, evidence-based treatment and longitudinal harm reduction.
Bipolar disorder diagnosis and episode management
VA/DoD-aligned diagnostic triage, phase-specific treatment, maintenance planning and high-risk escalation for adult bipolar disorder.
First-episode psychosis and schizophrenia care
VA/DoD-aligned early recognition, medical and substance differential, coordinated specialty care and antipsychotic safety monitoring.
Eating-disorder assessment and treatment planning
APA-aligned comprehensive assessment, medical-stability triage, diagnosis-specific psychotherapy and coordinated nutrition rehabilitation.
Suicide-related self-harm assessment and safety planning
VA/DoD-aligned identification, comprehensive suicide-risk assessment, collaborative safety planning and risk-tailored disposition.
PTSD assessment and evidence-based treatment
VA/DoD-aligned diagnostic assessment, trauma-focused psychotherapy, selected pharmacotherapy and comorbidity-aware follow-up.
Perinatal mental-health screening and treatment
ACOG-aligned universal screening with care systems, bipolar assessment, individualized treatment and emergency postpartum escalation.
Delirium: recognition, cause-finding and safer management
A deliberately bounded AGS postoperative and SCCM ICU delirium summary with multicomponent care and source-specific medication limits.
Iron-deficiency anemia: confirmation, cause and replacement
AGA-based confirmation, bleeding and malabsorption investigation, oral or intravenous iron and response monitoring.
Falls assessment and prevention in older adults
USPSTF and CDC STEADI risk identification, injury assessment, exercise and individualized multifactorial intervention.
Older adults with multimorbidity: priorities and coordinated decisions
AGS priority-, trajectory- and burden-aware decisions when multiple disease guidelines and treatments conflict.
Vitamin B12 and folate deficiency anemia
NIH biochemical evidence and current US label safety for assessment and replacement of vitamin B12 and folate deficiency.
Symptomatic lower-extremity varicose veins
North American multisociety evaluation, duplex confirmation, conservative options and preference-sensitive superficial venous intervention.
Chronic leg-ulcer infection: source boundary
A transparent account of why the attached US society records do not establish a current chronic leg-ulcer infection pathway.
Raynaud's phenomenon recognition and triage
ACR educational recognition material for Raynaud phenomenon, with testing and medication selection kept outside the source scope.
Venous leg-ulcer management: archived-source boundary
A source-status summary explaining why the attached society records do not support a current active venous-leg-ulcer management pathway.
Chronic noncancer pain assessment and safer treatment
US person-centered chronic-pain evaluation, multimodal nonopioid care and flexible CDC/VA-DoD opioid safety principles.
Painful diabetic polyneuropathy treatment
AAN guidance on oral, topical and nonpharmacologic treatment options for adults with established painful diabetic polyneuropathy.
Palliative care and end-of-life planning
US serious-illness palliative assessment, symptom and caregiver support, advance-care planning and clear separation from the Medicare hospice benefit.
Anaphylaxis recognition, emergency treatment and follow-up
JTFPP-based immediate epinephrine treatment, physiologic support, observation decisions and prevention after anaphylaxis.
Urticaria and angioedema outside anaphylaxis
Acute urticaria phenotype, important mimics and emergency safety boundaries, with chronic drug sequencing kept outside scope.
Head injury assessment and early management
Age-appropriate emergency assessment, selective imaging, safe discharge and graded recovery using current ACEP and CDC sources.
Tobacco smoking dependence assessment and treatment
USPSTF and ATS-informed behavioral support, pharmacotherapy and longitudinal relapse care with pregnancy and vaping evidence boundaries.
Medication reconciliation and safer transitions
AHRQ-based medication-history verification, discrepancy resolution, transition communication and federal adverse-event reporting.
Recognition and evaluation of suspected child physical abuse
AAP-based recognition, trauma-informed examination and documentation, protective reporting and state-law boundaries.
Suspected sepsis and septic shock
Current adult and pediatric Surviving Sepsis Campaign priorities for immediate recognition, resuscitation, antimicrobials, source control, reassessment and US hospital implementation.
Fever in children younger than 5 years
Age-stratified US assessment of a febrile young child, with separate pathways for young infants, source-directed evaluation, sepsis screening and safe disposition.
Meningococcal disease: CDC clinical guidance
Current CDC recognition, diagnostic testing, empiric treatment and carriage-eradication guidance for suspected meningococcal disease.
Bronchiolitis in infants and young children
Clinical diagnosis and supportive management of uncomplicated bronchiolitis, with explicit exclusion criteria and escalation for respiratory failure, apnea or dehydration.
Acute gastroenteritis and dehydration in children younger than 5 years
Hydration-first management with source-directed stool testing, early nutrition, antimicrobial stewardship and escalation for shock or a surgical presentation.
Viral croup: assessment and management
Severity-based management of barking cough and stridor with minimal agitation, corticosteroid treatment, nebulized epinephrine when indicated and airway escalation.
Urinary tract infection in children and adolescents
Probability-based urine testing, uncontaminated collection, urinalysis-plus-culture diagnosis, local antimicrobial selection, result follow-up and selective imaging.
Functional constipation in children and adolescents
Current AGA–NASPGHAN assessment and stepwise care emphasizing clinical diagnosis, alarm features, disimpaction, maintenance, behavioral support and escalation.
Neonatal hyperbilirubinemia in infants born at 35 weeks or later
AAP 2022 bilirubin measurement, hour-specific risk assessment, feeding support, follow-up and urgent escalation for infants born at 35 weeks or later.
Febrile seizures in young children
Classification, emergency seizure care, fever-source assessment, restraint in testing after a simple event and escalation after complex or atypical seizures.